HTA dossier development

Specialist research organizations that build the economic and clinical-outcomes evidence pharmaceutical and biotech companies need to justify a product's value to payers and health-technology-assessment bodies — modeling cost-effectiveness, synthesizing real-world evidence and preparing HTA dossiers.